Prospective investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic

Vojtěch Thon, Pavel Piler, Tomáš Pavlík, Lenka Andrýsková, Kamil Doležel, David Kostka, Hynek Pikhart, Martin Bobák, Jana Klánová
doi: https://doi.org/10.1101/2022.07.21.22277881

Article usage

Article usage: July 2022 to January 2025

AbstractFullPdf
Jul 2022921147405
Aug 2022177730
Sep 202271420
Oct 202267021
Nov 202278013
Dec 20225207
Jan 202354514
Feb 202326212
Mar 20232937
Apr 202319511
May 20231925
Jun 20231653
Jul 2023711
Aug 202317106
Sep 20231243
Oct 20231641
Nov 20231932
Dec 2023900
Jan 2024810
Feb 2024722
Mar 2024902
Apr 2024824
May 2024603
Jun 20241102
Jul 2024506
Aug 20241612
Sep 20241935
Oct 20242370
Nov 20242106
Dec 20241913
Jan 2025110
Back to top
Posted July 22, 2022.
Download PDF
Data/Code
Email
Prospective investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic
Vojtěch Thon, Pavel Piler, Tomáš Pavlík, Lenka Andrýsková, Kamil Doležel, David Kostka, Hynek Pikhart, Martin Bobák, Jana Klánová
medRxiv 2022.07.21.22277881; doi: https://doi.org/10.1101/2022.07.21.22277881
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area